{"id":"https://openalex.org/W2129307997","doi":"https://doi.org/10.18632/oncotarget.2568","title":"A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours","display_name":"A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours","publication_year":2014,"publication_date":"2014-10-23","ids":{"openalex":"https://openalex.org/W2129307997","doi":"https://doi.org/10.18632/oncotarget.2568","mag":"2129307997","pmid":"https://pubmed.ncbi.nlm.nih.gov/25525888","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4294348"},"language":"en","primary_location":{"id":"doi:10.18632/oncotarget.2568","doi":"https://doi.org/10.18632/oncotarget.2568","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.2568","pdf_url":"https://www.oncotarget.com/article/2568/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.oncotarget.com/article/2568/pdf/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026095888","display_name":"David S. Hong","orcid":"https://orcid.org/0000-0001-8721-1609","observed_orcids":["https://orcid.org/0000-0001-8721-1609"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David S. Hong","raw_affiliation_strings":["Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX 77230-1402, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX 77230-1402, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Razelle Kurzrock","raw_affiliation_strings":["Center for Personalized Cancer Therapy and CTO, Division of Hematology and Oncology, UC San Diego Moores Cancer Center, 3855 Health Sciences Drive, MC #0658, La Jolla, CA 92093-0658, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Personalized Cancer Therapy and CTO, Division of Hematology and Oncology, UC San Diego Moores Cancer Center, 3855 Health Sciences Drive, MC #0658, La Jolla, CA 92093-0658, USA","institution_ids":["https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112047718","display_name":"Marilyn Mulay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marilyn Mulay","raw_affiliation_strings":["Mulay Educational and Clinical Consulting Associates, 12412 Texas Ave., Suite 206, Los Angeles, CA 90025, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mulay Educational and Clinical Consulting Associates, 12412 Texas Ave., Suite 206, Los Angeles, CA 90025, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001183616","display_name":"Erik Rasmussen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erik Rasmussen","raw_affiliation_strings":["Department of Biostatistics, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033819205","display_name":"Benjamin M. Wu","orcid":"https://orcid.org/0000-0001-6443-3671","observed_orcids":["https://orcid.org/0000-0001-6443-3671"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin M. Wu","raw_affiliation_strings":["Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030048029","display_name":"Michael Bass","orcid":"https://orcid.org/0000-0002-7732-6557","observed_orcids":["https://orcid.org/0000-0002-7732-6557"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael B. Bass","raw_affiliation_strings":["Department of Molecular Sciences and Computational Biology, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Sciences and Computational Biology, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109954335","display_name":"Zhandong Don Zhong","orcid":"https://orcid.org/0009-0009-7983-4860","observed_orcids":["https://orcid.org/0009-0009-7983-4860"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhandong D. Zhong","raw_affiliation_strings":["Department of Clinical Immunology and Biological Sample Management, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology and Biological Sample Management, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003380386","display_name":"Greg Friberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Greg Friberg","raw_affiliation_strings":["Department of Early Development, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Early Development, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037497042","display_name":"Lee S. Rosen","orcid":"https://orcid.org/0000-0003-2503-6133","observed_orcids":["https://orcid.org/0000-0003-2503-6133"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lee S. Rosen","raw_affiliation_strings":["Department of Medicine, Division of Hematology and Oncology, UCLA, Santa Monica, CA 90404, USA","University of California at Los Angeles**"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology and Oncology, UCLA, Santa Monica, CA 90404, USA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"University of California at Los Angeles**","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0926,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.76110482,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"5","issue":"22","first_page":"11154","last_page":"11167"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trebananib","display_name":"trebananib","score":0.9789999723434448},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9760000109672546},{"id":"https://openalex.org/keywords/motesanib","display_name":"motesanib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tie2-receptor","display_name":"Tie2 receptor","score":0.6779999732971191},{"id":"https://openalex.org/keywords/vegf-inhibition","display_name":"VEGF inhibition","score":0.6729999780654907},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.7229999899864197},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6859999895095825},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8230000138282776},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.48500001430511475},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6759999990463257},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.3400000035762787},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.3310000002384186},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.36399999260902405},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.628000020980835},{"id":"https://openalex.org/keywords/angiopoietin-2","display_name":"angiopoietin-2","score":0.5479999780654907},{"id":"https://openalex.org/keywords/angiopoietin-4","display_name":"angiopoietin-4","score":0.8659999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.601243793964386},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.460258811712265},{"id":"https://openalex.org/C161191863","wikidata":"https://www.wikidata.org/wiki/Q199655","display_name":"Library science","level":1,"score":0.4361268877983093},{"id":"https://openalex.org/C2776598537","wikidata":"https://www.wikidata.org/wiki/Q1812651","display_name":"Clinical Oncology","level":3,"score":0.4216918349266052},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.41264134645462036},{"id":"https://openalex.org/C74909509","wikidata":"https://www.wikidata.org/wiki/Q10387","display_name":"Gerontology","level":1,"score":0.3461969196796417},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33163216710090637},{"id":"https://openalex.org/C187736073","wikidata":"https://www.wikidata.org/wiki/Q2920921","display_name":"Management","level":1,"score":0.32236725091934204},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3206532299518585},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.311226487159729},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.18632/oncotarget.2568","doi":"https://doi.org/10.18632/oncotarget.2568","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.2568","pdf_url":"https://www.oncotarget.com/article/2568/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4294348","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4294348","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Text"},{"id":"pmid:25525888","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25525888","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:escholarship.org/ark:/13030/qt9mw523gx","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/9mw523gx","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Oncotarget, vol 5, iss 22","raw_type":"article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt9mw523gx","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/9mw523gx","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Oncotarget, vol 5, iss 22","raw_type":"article"}],"best_oa_location":{"id":"doi:10.18632/oncotarget.2568","doi":"https://doi.org/10.18632/oncotarget.2568","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.2568","pdf_url":"https://www.oncotarget.com/article/2568/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G1620252213","display_name":"Center for Clinical and Translational Sciences (CCTS)","funder_award_id":"UL1TR000371","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2129307997.pdf","grobid_xml":"https://content.openalex.org/works/W2129307997.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W1783580437","https://openalex.org/W1977999028","https://openalex.org/W1980459448","https://openalex.org/W1996859043","https://openalex.org/W1997761243","https://openalex.org/W2006202974","https://openalex.org/W2015007424","https://openalex.org/W2035627783","https://openalex.org/W2041766813","https://openalex.org/W2046507292","https://openalex.org/W2049792735","https://openalex.org/W2066620809","https://openalex.org/W2066888615","https://openalex.org/W2070563197","https://openalex.org/W2083005649","https://openalex.org/W2095235698","https://openalex.org/W2099028752","https://openalex.org/W2100785570","https://openalex.org/W2107783310","https://openalex.org/W2108923852","https://openalex.org/W2113122060","https://openalex.org/W2117713501","https://openalex.org/W2120022879","https://openalex.org/W2122927195","https://openalex.org/W2129820508","https://openalex.org/W2130105793","https://openalex.org/W2132827381","https://openalex.org/W2139248078","https://openalex.org/W2145835533","https://openalex.org/W2150108534","https://openalex.org/W2150452646","https://openalex.org/W2151752381","https://openalex.org/W2152215024","https://openalex.org/W2157099922","https://openalex.org/W2157769714","https://openalex.org/W2158695915","https://openalex.org/W2166259130","https://openalex.org/W2166788033","https://openalex.org/W2170770755","https://openalex.org/W2342290687","https://openalex.org/W2524108683","https://openalex.org/W2616016268","https://openalex.org/W2793323124","https://openalex.org/W3143779563"],"related_works":["https://openalex.org/W2778315923","https://openalex.org/W1995264751","https://openalex.org/W4254524519","https://openalex.org/W7096923140","https://openalex.org/W1805178690","https://openalex.org/W2613906279","https://openalex.org/W3011495178","https://openalex.org/W2890800515","https://openalex.org/W1846318821","https://openalex.org/W2244888982"],"abstract_inverted_index":{"//":[0],"David":[1,219],"S.":[2,38,220],"Hong":[3],"1":[4,41],",":[5,9,13,17,22,27,32,36],"Razelle":[6],"Kurzrock":[7],"2":[8,67,379],"Marilyn":[10],"Mulay":[11,98],"3":[12,97,279,532],"Erik":[14],"Rasmussen":[15],"4":[16,114],"Benjamin":[18],"M.":[19],"Wu":[20],"5":[21,129],"Michael":[23],"B.":[24],"Bass":[25],"6":[26,147],"Zhandong":[28],"D.":[29],"Zhong":[30],"7":[31,166],"Greg":[33],"Friberg":[34],"8":[35,186],"Lee":[37],"Rosen":[39],"9":[40,202],"Department":[42,115,130,148,167,187,203],"of":[43,48,52,76,116,131,149,168,188,204,207,322,354,368],"Investigational":[44],"Cancer":[45,49,56,71,84],"Therapeutics,":[46],"Division":[47,75,206],"Medicine,":[50,205],"University":[51],"Texas":[53,105],"MD":[54],"Anderson":[55],"Center,":[57,85],"1515":[58],"Holcombe":[59],"Blvd,":[60],"Unit":[61],"455,":[62],"Houston,":[63],"TX":[64],"77230\u20131402,":[65],"USA":[66,96,113,128,146,165,185,201,216],"Center":[68,122,140,159,179,195],"for":[69],"Personalized":[70],"Therapy":[72],"and":[73,78,100,133,152,171,209,338,344,372,380,418,469],"CTO,":[74],"Hematology":[77,208],"Oncology,":[79,210],"UC":[80],"San":[81],"Diego":[82],"Moores":[83],"3855":[86],"Health":[87],"Sciences":[88,151],"Drive,":[89,123,141,160,180,196],"MC":[90],"#0658,":[91],"La":[92],"Jolla,":[93],"CA":[94,111,126,144,163,183,199,214],"92093\u20130658,":[95],"Educational":[99],"Clinical":[101,169],"Consulting":[102],"Associates,":[103],"12412":[104],"Ave.,":[106],"Suite":[107],"206,":[108],"Los":[109],"Angeles,":[110],"90025,":[112],"Biostatistics,":[117],"Amgen":[118,121,136,139,155,158,175,178,191,194],"Inc.,":[119,137,156,176,192],"One":[120,138,157,177,193],"Thousand":[124,142,161,181,197],"Oaks,":[125,143,162,182,198],"91320,":[127,145,164,184,200],"Pharmacokinetics":[132],"Drug":[134],"Metabolism,":[135],"Molecular":[150],"Computational":[153],"Biology,":[154],"Immunology":[170],"Biological":[172],"Sample":[173],"Management,":[174],"Early":[189],"Development,":[190],"UCLA,":[211],"Santa":[212],"Monica,":[213],"90404,":[215],"Correspondence":[217],"to:":[218],"Hong,":[221],"e-mail:":[222],"dshong@mdanderson.org":[223],"Keywords:":[224],"angiogenesis,":[225],"angiopoietins,":[226],"Tie2":[227],"receptor,":[228],"vascular":[229],"endothelial":[230],"growth":[231],"factor,":[232],"angiogenic":[233],"inhibitors":[234],"Received:":[235],"June":[236],"19,":[237,365],"2014":[238,242,246],"Accepted:":[239],"October":[240,244],"02,":[241],"Published:":[243],"23,":[245],"ABSTRACT":[247],"Background:":[248],"To":[249],"examine":[250],"the":[251,258,393,434,439,490,510],"angiopoietin":[252],"pathway":[253],"inhibitor":[254],"trebananib":[255,278,301,355,389,435,491,511],"IV":[256,277,531],"plus":[257,284,306,390,436,492,512,541],"anti-VEGF":[259,563],"agents":[260],"bevacizumab":[261,285,307,391,493,542],"or":[262,293,300,314,536,543],"motesanib":[263,294,315,437,487,513,544],"in":[264,377,545],"advanced":[265,546],"solid":[266,547],"tumours.":[267],"Methods:":[268],"In":[269],"this":[270],"open-label":[271],"phase":[272],"1b":[273],"study,":[274],"patients":[275,323,350,425,477,496,502,522],"received":[276,351],"mg":[280,287,297,303,309,317,533,538],"kg":[281,288,304,310,534,539],"\u22121":[282,289,305,311,535,540],"QW":[283],"15":[286,308],"Q3W":[290],"(cohort":[291,298,312,318],"1)":[292],"orally":[295],"75":[296],"2);":[299],"10":[302,537],"3)":[313],"125":[316],"4).":[319],"If":[320],"<33%":[321],"had":[324,429,478,497,503,517,523],"dose-limiting":[325],"toxicities":[326,555],"(DLTs),":[327],"dose":[328,353],"escalation":[329],"occurred.":[330],"Endpoints":[331],"were":[332],"treatment\u2013related":[333],"adverse":[334],"events":[335],"(AEs)":[336],"incidence":[337],"pharmacokinetics":[339],"(primary);":[340],"anti-trebananib":[341],"antibodies,":[342],"biomarkers,":[343],"tumour":[345],"response":[346],"(secondary).":[347],"Results:":[348],"Thirty-six":[349],"\u22651":[352],"(cohorts":[356],"1,":[357],"2,":[358],"3,":[359,381],"4;":[360],"n":[361,384,400,405,410,415,421,446,451,456,461,466,473],"=":[362,385,401,406,411,416,422,447,452,457,462,467,474],"6,":[363],"8,":[364],"3).":[366,423],"DLT":[367],"G3":[369,373],"intestinal":[370],"perforation":[371],"tumor":[374],"haemorrhage":[375],"occurred":[376],"cohorts":[378,428],"respectively":[382],"(both":[383],"1).":[386],"Across":[387,433,489,509],"both":[388],"cohorts,":[392,438,494,514],"most":[394,440],"common":[395,441],"AEs":[396,442],"included":[397,443],"fatigue":[398,459],"(":[399,404,409,414,420,445,450,455,460,465,472],"8),":[402],"diarrhoea":[403,449],"4),":[407,448,453],"constipation":[408],"3),":[412,417,458,463],"nausea":[413,454],"epistaxis":[419],"Three":[424],"across":[426],"those":[427,558],"grade":[430,479],"\u22653":[431,480],"AEs.":[432,481],"hypertension":[444],"vomiting":[464],"2),":[468],"decreased":[470],"appetite":[471],"2).":[475],"Two":[476],"Trebananib":[482,530],"did":[483],"not":[484],"markedly":[485],"affect":[486],"pharmacokinetics.":[488],"two":[495,562],"a":[498,518],"partial":[499,519],"response;":[500,520],"11":[501],"stable":[504,524],"disease":[505,525],"lasting":[506,526],">6":[507,527],"months.":[508,528],"one":[515],"patient":[516],"five":[521],"Conclusion:":[529],"tumours":[548],"may":[549],"be":[550],"associated":[551],"with":[552],"less":[553],"severe":[554],"relative":[556],"to":[557],"emerging":[559],"when":[560],"combining":[561],"agents.":[564]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}